Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Bloom

Showing results (151-160 of 252) with videos related to

Pageof 26
Sort By:
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 8, 2011
Gastric bypass reduces fat intake and preferenceCarel W le Roux, Marco Bueter, Nadine Theis, et al.
Diabetes, Obesity & Metabolism|February 22, 2023
Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single-blind placebo-controlled studyPreeshila Behary, Haya Alessimii, Alexander D Miras, et al.
Endocrinology|May 14, 2005
Hypothalamic cocaine- and amphetamine-regulated transcript (CART) and agouti-related protein (AgRP) neurons coexpress the NOP1 receptor and nociceptin alters CART and AgRP releaseGavin A Bewick, Waljit S Dhillo, Sarah J Darch, et al.
Diabetes, Obesity & Metabolism|September 29, 2020
Imperial Satiety Protocol: A new non-surgical weight-loss programme, delivered in a health care setting, produces improved clinical outcomes for people with obesitySaira Hameed, Victoria Salem, Haya Alessimii, et al.
Annals of Surgery|November 26, 2010
Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomesDimitrios J Pournaras, Alan Osborne, Simon C Hawkins, et al.
Annals of Surgery|June 22, 2010
Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferationCarel W le Roux, Cynthia Borg, Katharina Wallis, et al.
Annals of Clinical Biochemistry|August 30, 2014
The identification of elevated urinary kisspeptin-immunoreactivity during pregnancyChanna N Jayasena, Alexander N Comninos, Shakunthala Narayanaswamy, et al.
Clinical Endocrinology|December 20, 2011
Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assaysRadha Ramachandran, Paul Bech, Kevin G Murphy, et al.
Endocrinology|August 21, 2012
Low degree of overlap between kisspeptin, neurokinin B, and dynorphin immunoreactivities in the infundibular nucleus of young male human subjects challenges the KNDy neuron conceptErik Hrabovszky, Máté T Sipos, Csilla S Molnár, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
The effect of slow spaced eating on hunger and satiety in overweight and obese patients with type 2 diabetes mellitusTheodoros Angelopoulos, Alexander Kokkinos, Christos Liaskos, et al.
Pageof 26

Showing results (151-160 of 252) with videos related to

Sort By:
Pageof 26
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 8, 2011
Gastric bypass reduces fat intake and preferenceCarel W le Roux, Marco Bueter, Nadine Theis, et al.
Diabetes, Obesity & Metabolism|February 22, 2023
Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single-blind placebo-controlled studyPreeshila Behary, Haya Alessimii, Alexander D Miras, et al.
Endocrinology|May 14, 2005
Hypothalamic cocaine- and amphetamine-regulated transcript (CART) and agouti-related protein (AgRP) neurons coexpress the NOP1 receptor and nociceptin alters CART and AgRP releaseGavin A Bewick, Waljit S Dhillo, Sarah J Darch, et al.
Diabetes, Obesity & Metabolism|September 29, 2020
Imperial Satiety Protocol: A new non-surgical weight-loss programme, delivered in a health care setting, produces improved clinical outcomes for people with obesitySaira Hameed, Victoria Salem, Haya Alessimii, et al.
Annals of Surgery|November 26, 2010
Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomesDimitrios J Pournaras, Alan Osborne, Simon C Hawkins, et al.
Annals of Surgery|June 22, 2010
Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferationCarel W le Roux, Cynthia Borg, Katharina Wallis, et al.
Annals of Clinical Biochemistry|August 30, 2014
The identification of elevated urinary kisspeptin-immunoreactivity during pregnancyChanna N Jayasena, Alexander N Comninos, Shakunthala Narayanaswamy, et al.
Clinical Endocrinology|December 20, 2011
Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assaysRadha Ramachandran, Paul Bech, Kevin G Murphy, et al.
Endocrinology|August 21, 2012
Low degree of overlap between kisspeptin, neurokinin B, and dynorphin immunoreactivities in the infundibular nucleus of young male human subjects challenges the KNDy neuron conceptErik Hrabovszky, Máté T Sipos, Csilla S Molnár, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
The effect of slow spaced eating on hunger and satiety in overweight and obese patients with type 2 diabetes mellitusTheodoros Angelopoulos, Alexander Kokkinos, Christos Liaskos, et al.
Pageof 26